A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Grifols Sa stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 465,768 shares of GRFS stock, worth $3.56 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
465,768
Previous 596,845 21.96%
Holding current value
$3.56 Million
Previous $3.76 Million 10.0%
% of portfolio
0.01%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$6.28 - $9.38 $823,163 - $1.23 Million
-131,077 Reduced 21.96%
465,768 $4.14 Million
Q2 2024

Aug 14, 2024

BUY
$6.27 - $7.7 $2.84 Million - $3.49 Million
453,700 Added 316.95%
596,845 $3.76 Million
Q1 2024

May 15, 2024

SELL
$5.47 - $11.38 $4.22 Million - $8.79 Million
-772,255 Reduced 84.36%
143,145 $956,000
Q4 2023

Feb 14, 2024

SELL
$7.71 - $11.56 $20.1 Million - $30.2 Million
-2,610,575 Reduced 74.04%
915,400 $10.6 Million
Q3 2023

Nov 14, 2023

BUY
$8.91 - $10.91 $14.4 Million - $17.6 Million
1,617,275 Added 84.73%
3,525,975 $32.2 Million
Q2 2023

Aug 14, 2023

BUY
$7.14 - $9.29 $13.6 Million - $17.7 Million
1,908,700 New
1,908,700 $17.5 Million
Q3 2022

Nov 14, 2022

BUY
$5.95 - $14.3 $12.8 Million - $30.7 Million
2,149,771 Added 919.38%
2,383,600 $14.7 Million
Q2 2022

Aug 15, 2022

BUY
$10.6 - $13.28 $2.48 Million - $3.11 Million
233,829 New
233,829 $2.78 Million
Q2 2020

Aug 14, 2020

SELL
$18.24 - $21.45 $7.65 Million - $9 Million
-419,620 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$16.28 - $25.63 $12,698 - $19,991
-780 Reduced 0.19%
419,620 $8.45 Million
Q4 2019

Feb 14, 2020

SELL
$19.57 - $23.52 $6.09 Million - $7.32 Million
-311,342 Reduced 42.55%
420,400 $9.79 Million
Q3 2019

Nov 15, 2019

BUY
$19.85 - $22.76 $14.5 Million - $16.7 Million
731,742 New
731,742 $14.7 Million

Others Institutions Holding GRFS

About Grifols SA


  • Ticker GRFS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 678,910,976
  • Market Cap $5.19B
  • Description
  • Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...
More about GRFS
Track Steven Cohen's Portfolio

Track Steven Cohen Portfolio

Follow Steven Cohen (Point72 Asset Management, L.P.) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.